Skip to main content

Market Overview

Abbott Laboratories And More On CNBC's 'Final Trades'

Share:
Abbott Laboratories And More On CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Innovator U.S. Equity Power Buffer ETF October (NYSE: POCT) as her final trade.

Stephen Weiss of Short Hills Capital Partners picked U.S. 10 Year Treasury Note .

Don’t forget to check out our premarket coverage here

Brenda Vingiello of Sand Hill Global Advisors named Abbott Laboratories (NYSE: ABT) as his final trade.

In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. Abbott recently agreed to acquire Bigfoot Biomedical. However, financial terms of the deal were not disclosed.

Shannon Saccocia of Boston Private picked Vanguard Real Estate Index Fund (NYSE: VNQ).

Price Action: Abbott Laboratories shares gained 2.7% to close at $98.12 on Thursday.
Check This Out: Nike, Carnival And 3 Stocks To Watch Heading Into Friday

 

Related Articles (ABT + POCT)

View Comments and Join the Discussion!

Posted-In: Brenda Vingiello Bryn TalkingtonLong Ideas News Top Stories Markets Media Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com